Accenture (ACN)
(Delayed Data from NYSE)
$341.95 USD
+1.74 (0.51%)
Updated Aug 30, 2024 04:00 PM ET
After-Market: $341.85 -0.10 (-0.03%) 4:24 PM ET
4-Sell of 5 4
D Value B Growth B Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$341.95 USD
+1.74 (0.51%)
Updated Aug 30, 2024 04:00 PM ET
After-Market: $341.85 -0.10 (-0.03%) 4:24 PM ET
4-Sell of 5 4
D Value B Growth B Momentum C VGM
Zacks News
Years of investment in digital, cloud and security strategy has helped Accenture evolve as a trusted and viable consulting services provider. It is currently the world’s top consultancy firm by revenues that increased 5% in 2019 with a contribution of 56% from consulting services.
How Accenture (ACN) Stock Stands Out in a Strong Industry
by Zacks Equity Research
Accenture (ACN) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
Accenture (ACN) Q2 Earnings, Revenues Top Estimates, View Up
by Zacks Equity Research
Accenture's (ACN) second-quarter fiscal 2022 earnings benefit from higher revenues and operating results, lower non-operating expenses.
Accenture (ACN) Q2 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Accenture (ACN) delivered earnings and revenue surprises of 7.63% and 2.69%, respectively, for the quarter ended February 2022. Do the numbers hold clues to what lies ahead for the stock?
Accenture (ACN) Moves to Buy: Rationale Behind the Upgrade
by Zacks Equity Research
Accenture (ACN) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Reasons to Add Maximus (MMS) Stock to Your Portfolio Now
by Zacks Equity Research
With more than 40 years of experience, Maximus has grown to be a leading operator of government health and human services programs globally.
Should iShares MSCI USA Min Vol Factor ETF (USMV) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for USMV
What's in the Cards for Accenture (ACN) in Q2 Earnings?
by Zacks Equity Research
Accenture's (ACN) second-quarter fiscal 2022 earnings and revenues are expected to have improved year over year.
Affirm (AFRM) Down 15% Despite Raising Guidance: Here's Why
by Zacks Equity Research
Affirm Holdings (AFRM) boosts fiscal 2022 revenue less transaction costs' guidance to at least $600 million from the previous range of $585-$595 million.
US Stock Market Consolidates Ahead Of The Fed's Pivotal Liftoff Meeting
by Daniel Laboe
Get ready for what promises to be one of the most important weeks of market-moving action as investors' focus shifts towards the Federal Reserve
Global Payments (GPN): Story of an Undervalued Cashflow Beast
by Zacks Equity Research
Global Payments (GPN) enhances its share buyback program by increasing the available fund to $2 billion.
Accenture (ACN) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Accenture (ACN) closed at $311.58 in the latest trading session, marking a +0.67% move from the prior day.
6 Reasons to Add Robert Half (RHI) Stock to Your Portfolio Now
by Zacks Equity Research
Robert Half's (RHI) wholly-owned subsidiary, Protiviti, is strongly positioned in the market, and is also a solid revenue performer.
Reasons to Retain FactSet (FDS) Stock in Your Portfolio
by Zacks Equity Research
The recent acquisition of Cobalt Software is expected to enhance FactSet's (FDS) data and workflow solutions, and expand its private markets offering.
5 Reasons to Add ABM Industries (ABM) Stock to Your Portfolio
by Zacks Equity Research
The acquisition of Able Services is expected to strengthen ABM Industries' engineering and technical services, and expand its sustainability and energy efficiency offerings.
Information Services Group (III) Meets Q4 Earnings Estimates
by Zacks Equity Research
ISG (III) delivered earnings and revenue surprises of 0% and 2.35%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?
Accenture (ACN) Gains As Market Dips: What You Should Know
by Zacks Equity Research
In the latest trading session, Accenture (ACN) closed at $309.52, marking a +0.03% move from the previous day.
The Zacks Analyst Blog Highlights UnitedHealth Group, Accenture, Union Pacific, The Boeing Company and Prologis
by Zacks Equity Research
UnitedHealth Group, Accenture, Union Pacific, The Boeing Company and Prologis are included in this blog.
Reasons to Hold Trane Technologies (TT) in Your Portfolio
by Zacks Equity Research
Trane Technologies (TT) prioritizes improving its business operating system and innovation through transformation initiatives and investments.
Top Research Reports for UnitedHealth, Accenture & Union Pacific
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including UnitedHealth Group Incorporated (UNH), Accenture plc (ACN) and Union Pacific Corporation (UNP).
Republic Services (RSG) Benefits From Acquisitions, Debt Ails
by Zacks Equity Research
Republic Services' (RSG) top line benefits from the favorable impact of acquisitions and internal growth.
Here's Why You Should Hold on to S&P Global (SPGI) Stock Now
by Zacks Equity Research
S&P Global's (SPGI) focus on improving foundational capabilities and core businesses with a view to enhance and differentiate customer experience.
Verisk Analytics (VRSK) Up 7.5% in a Year: What's Behind It?
by Zacks Equity Research
Consecutive better-than-expected bottom-line performance, shareholder-friendly moves and contributions from acquisitions have been benefiting Verisk's (VRSK) stock.
CRAI or ACN: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
CRAI vs. ACN: Which Stock Is the Better Value Option?
Rollins (ROL) Continues to Ride on Acquisitions as Debt Ails
by Zacks Equity Research
Rollins (ROL) is a consistent dividend payer with a balanced approach to organic and inorganic growth.
6 Reasons Why You Should Invest in Clean Harbors (CLH) Stock
by Zacks Equity Research
Strategic capital investments with improved business efficiency, diversified service offerings and buyouts should drive Clean Harbors' (CLH) prospects.